Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
lee011 | cyclin-dependent kinase 4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Malignant neoplasm of breast[MeSHID:D001943] |
1.28 | phase 3 | unknown |
lee011 | cyclin-dependent kinase 4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Malignant neoplasm of breast[MeSHID:D001943] |
1.28 | phase 3 | inhibitor |
lee011 | cyclin-dependent kinase 6 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Malignant neoplasm of breast[MeSHID:D001943] |
1.55 | phase 3 | inhibitor |
lee011 | cyclin-dependent kinase 6 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Malignant neoplasm of breast[MeSHID:D001943] |
1.55 | phase 3 | unknown |
click here to return to the previous page |